Schauer U J, Pissarek D, Lundershausen R, Rühling K, Winkler L, Panzram G
Outpatient Department of Internal Medicine, Medical Academy Erfurt G.D.R.
Exp Clin Endocrinol. 1988 Mar;92(3):280-6. doi: 10.1055/s-0029-1210816.
Follow-up data of all 208 long-term diabetics (duration of the disease at least 20 years) living in the closed area of the Erfurt district in 1970 had demonstrated the importance of lipoprotein pattern for longevity. Now the dependence of lipoprotein levels on both the diabetes-related conditions nephropathy and glycaemic control has been examined in 47 of them, still alive in 1985 that means 35 or more years after the onset of diabetes. Glycaemic control was assessed by measuring the glycosylated haemoglobin (n = 44). Diabetic nephropathy was assumed in case of persistent proteinuria. Poor glycaemic control (n = 16) was associated with increased levels of atherogenic lipoproteins as reflected by higher concentrations of total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides, as well as a changed HDL composition indicated by a decreased HDL cholesterol/apolipoprotein A--I ratio. Higher ratios of total cholesterol to HDL cholesterol and apolipoprotein B to apolipoprotein A--I point to an increased risk of developing atherosclerotic diseases in poorly controlled diabetics. 86% of the well controlled long-term diabetics had non-pathological values of LDL cholesterol, triglycerides, apolipoprotein B, HDL cholesterol, and apolipoprotein A--I but only 31% of the poorly controlled patients did so. Diabetic nephropathy in the absence of chronic renal failure (n = 10) was characterized by higher values of LDL cholesterol, triglycerides, total cholesterol/HDL cholesterol, and apolipoprotein B/apolipoprotein A--I. 80% of the subjects with a pathological lipoprotein pattern were proteinuric or in poor glycaemic control or both. Therefore, it is concluded that prevention of these two conditions might help to delay atherosclerosis via its beneficial influence on lipoprotein metabolism.
1970年对居住在爱尔福特地区封闭区域内的所有208名长期糖尿病患者(病程至少20年)的随访数据表明,脂蛋白模式对寿命具有重要意义。现在,对其中47名患者(1985年仍在世,即糖尿病发病后35年或更长时间)的脂蛋白水平与糖尿病相关病症(肾病)和血糖控制之间的相关性进行了研究。通过测量糖化血红蛋白(n = 44)来评估血糖控制情况。持续性蛋白尿则被认定为患有糖尿病肾病。血糖控制不佳(n = 16)与致动脉粥样硬化脂蛋白水平升高有关,表现为总胆固醇、低密度脂蛋白胆固醇、载脂蛋白B和甘油三酯浓度升高,以及高密度脂蛋白胆固醇/载脂蛋白A - I比值降低所表明的高密度脂蛋白组成改变。总胆固醇与高密度脂蛋白胆固醇以及载脂蛋白B与载脂蛋白A - I的比值较高,表明血糖控制不佳的糖尿病患者发生动脉粥样硬化疾病的风险增加。血糖控制良好的长期糖尿病患者中,86%的患者低密度脂蛋白胆固醇、甘油三酯、载脂蛋白B、高密度脂蛋白胆固醇和载脂蛋白A - I的值无病理改变,但血糖控制不佳的患者中只有31%如此。无慢性肾衰竭的糖尿病肾病患者(n = 10)的特征是低密度脂蛋白胆固醇、甘油三酯、总胆固醇/高密度脂蛋白胆固醇和载脂蛋白B/载脂蛋白A - I的值较高。脂蛋白模式异常的患者中,80%存在蛋白尿或血糖控制不佳或两者皆有。因此,可以得出结论,预防这两种情况可能有助于通过对脂蛋白代谢产生有益影响来延缓动脉粥样硬化。